Act Hib Injection is indicated for providing protection against influenza caused by H. influenzae type b. It is a part of active immunization and is recommended at 2 months to 5 years of age. This injection is said to have ability to increase defense against Hib infections in children. It works by stimulating production of antibodies of child thus assures superior effectiveness. Act Hib Injection delivers long term effectiveness with no adverse health if administered by skilled physician or doctor. It can be availed at reasonable rates in large quantities by our respected clients.
Cash in Advance (CID), Cash Advance (CA)
500 Per Month
Main Export Market(s)
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Main Domestic Market
Other Products in 'Pharmaceutical Injection' You May Like